Security key
427746102
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)
CUSIP: 427746102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.01 per share
- Shares outstanding
- 182,615,507
- Total 13F shares
- 129,609,461
- Share change
- +10,065,549
- Total reported value
- $453,638,008
- Put/Call ratio
- 156%
- Price per share
- $3.50
- Number of holders
- 189
- Value change
- +$35,415,047
- Number of buys
- 109
- Number of sells
- 52
Report period
Q2 2024
Institutions
189
Top holders
10
HRTX full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
HERON THERAPEUTICS, INC. /DE/ SEC filings
HERON THERAPEUTICS, INC. /DE/ company facts
Broader feeds
Reporting periods
Holder history for CUSIP 427746102
Recent filing periods:
Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
13F
3/4/5
Large-stake signal
No latest 13D/G holder appears in this grouped view.
Evidence coverage
50 holder rows
Latest evidence as of 31 Mar 2024.
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
Company
|
15%
|
$73,996,403
26,713,503 shares
|
— | 31 Mar 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
5.5%
|
$28,008,994
10,111,550 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
4.4%
|
$22,477,763
8,114,716 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
4%
|
$20,182,297
7,286,028 shares
|
— | 31 Mar 2024 |
| Velan Capital Investment Management LP |
13F
3/4/5
Company · Other*
|
3.8%
|
$19,353,281
6,986,744 shares
|
— | 31 Mar 2024 |
| FRANKLIN RESOURCES INC |
13F
Company
|
3.5%
|
$17,657,598
6,374,584 shares
|
— | 31 Mar 2024 |
| Tejara Capital Ltd |
13F
Company
|
2.4%
|
$12,220,041
4,411,567 shares
|
— | 31 Mar 2024 |
| PALISADE CAPITAL MANAGEMENT, LP |
13F
Company
|
2%
|
$10,338,308
3,732,241 shares
|
— | 31 Mar 2024 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.7%
|
$8,773,382
3,167,286 shares
|
— | 31 Mar 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.6%
|
$8,060,730
2,910,011 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.5%
|
$7,746,588
2,796,119 shares
|
— | 31 Mar 2024 |
| Clearline Capital LP |
13F
Company
|
1.5%
|
$7,690,085
2,776,204 shares
|
— | 31 Mar 2024 |
| D. E. Shaw & Co., Inc. |
13F
Company
|
1.5%
|
$7,465,277
2,695,046 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
1.3%
|
$6,761,210
2,440,870 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
1.3%
|
$6,666,000
2,406,486 shares
|
— | 31 Mar 2024 |
| JW Asset Management, LLC |
13F
Company
|
1.3%
|
$6,349,998
2,292,418 shares
|
— | 31 Mar 2024 |
| Orchard Capital Management, LLC |
13F
Company
|
1.2%
|
$6,293,116
2,271,883 shares
|
— | 31 Mar 2024 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
1%
|
$5,124,500
1,850,000 shares
|
— | 31 Mar 2024 |
| Monaco Asset Management SAM |
13F
Company
|
0.99%
|
$5,022,464
1,813,164 shares
|
— | 31 Mar 2024 |
| Congress Park Capital LLC |
13F
Company
|
0.9%
|
$4,556,055
1,644,785 shares
|
— | 31 Mar 2024 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.77%
|
$3,879,119
1,400,404 shares
|
— | 31 Mar 2024 |
| Nuveen Asset Management, LLC |
13F
Company
|
0.6%
|
$3,032,283
1,094,687 shares
|
— | 31 Mar 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
Company
|
0.6%
|
$3,030,701
1,094,116 shares
|
— | 31 Mar 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
Company
|
0.6%
|
$3,022,452
1,091,138 shares
|
— | 31 Mar 2024 |
| NORTHERN TRUST CORP |
13F
Company
|
0.53%
|
$2,657,954
959,550 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0.31%
|
$1,588,420
573,437 shares
|
— | 31 Mar 2024 |
| Qube Research & Technologies Ltd |
13F
Company
|
0.31%
|
$1,556,696
561,984 shares
|
— | 31 Mar 2024 |
| MARSHALL WACE, LLP |
13F
Company
|
0.27%
|
$1,369,360
494,354 shares
|
— | 31 Mar 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
Company
|
0.27%
|
$1,366,341
493,264 shares
|
— | 31 Mar 2024 |
| NEXPOINT ASSET MANAGEMENT, L.P. |
13F
Company
|
0.26%
|
$1,317,828
475,750 shares
|
— | 31 Mar 2024 |
| ZACKS INVESTMENT MANAGEMENT |
13F
Company
|
0.24%
|
$1,209,031
436,473 shares
|
— | 31 Mar 2024 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
0.23%
|
$1,157,819
417,985 shares
|
— | 31 Mar 2024 |
| PANAGORA ASSET MANAGEMENT INC |
13F
Company
|
0.21%
|
$1,039,930
375,426 shares
|
— | 31 Mar 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
Company
|
0.19%
|
$938,000
338,526 shares
|
— | 31 Mar 2024 |
| Bank of New York Mellon Corp |
13F
Company
|
0.18%
|
$929,493
335,557 shares
|
— | 31 Mar 2024 |
| Zweig-DiMenna Associates LLC |
13F
Company
|
0.18%
|
$886,760
320,130 shares
|
— | 31 Mar 2024 |
| FMR LLC |
13F
Company
|
0.18%
|
$886,240
319,943 shares
|
— | 31 Mar 2024 |
| CM Management, LLC |
13F
Company
|
0.16%
|
$831,000
300,000 shares
|
— | 31 Mar 2024 |
| Richmond Brothers, Inc. |
13F
Company
|
0.16%
|
$821,876
296,706 shares
|
— | 31 Mar 2024 |
| KBC Group NV |
13F
Company
|
0.16%
|
$801,000
289,269 shares
|
— | 31 Mar 2024 |
| GSA CAPITAL PARTNERS LLP |
13F
Company
|
0.15%
|
$775,000
279,699 shares
|
— | 31 Mar 2024 |
| Informed Momentum Co LLC |
13F
Company
|
0.15%
|
$760,393
274,510 shares
|
— | 31 Mar 2024 |
| JANE STREET GROUP, LLC |
13F
Company
|
0.15%
|
$743,642
268,463 shares
|
— | 31 Mar 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.13%
|
$651,066
235,042 shares
|
— | 31 Mar 2024 |
| XTX Topco Ltd |
13F
Company
|
0.11%
|
$578,340
208,787 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
0.11%
|
$551,229
198,999 shares
|
— | 31 Mar 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.1%
|
$514,937
185,898 shares
|
— | 31 Mar 2024 |
| D.A. DAVIDSON & CO. |
13F
Company
|
0.09%
|
$473,670
171,000 shares
|
— | 31 Mar 2024 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
0.09%
|
$457,133
165,030 shares
|
— | 31 Mar 2024 |
| RHUMBLINE ADVISERS |
13F
Company
|
0.08%
|
$388,454
140,242 shares
|
— | 31 Mar 2024 |
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2024
As of 30 Jun 2024,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
189 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
129,609,461 shares.
The largest 10 holders included
Rubric Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Velan Capital Investment Management LP, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, Tejara Capital Ltd, and PALISADE CAPITAL MANAGEMENT, LP.
This page lists
190
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
157
Q2 2024 holders
189
Holder diff
32
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.